September 06, 2016

Amphastar Pharmaceuticals, Inc, et al v. Momenta Pharmaceuticals, Inc, et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. March 06, 2017

    Momenta Isn't Shielded From Antitrust Suit, 1st Circ. Says

    The First Circuit on Monday revived an antitrust suit alleging Momenta Inc. and Sandoz Inc. misled regulators about their patent on the industry test for an anticoagulant so they could squeeze rival Amphastar Pharmaceuticals Inc. out of the market with infringement claims, finding the district court erroneously applied the Noerr-Pennington doctrine.

7 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!